Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Borrelia burgdorferi outer surface protein A (OspA) is a major lipoprotein found on the surface of the Lyme disease spirochete, B. burgdorferi. OspA is highly immunogenic and plays a critical role in the bacterium’s life cycle, particularly during its residence in tick vectors. It is essential for colonization and survival within ticks and serves as a target for protective antibodies. Vaccines based on OspA have shown efficacy in preventing Lyme disease by blocking transmission at the tick stage.
Vaccines based on OspA elicit antibodies that block B. burgdorferi transmission from ticks to vertebrate hosts by binding to OspA within the tick gut, leading to spirochete death or preventing their migration to the salivary glands.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Borrelia burgdorferi Outer Surface Protein A (OspA).